Published on 10 February 2012
Generic clopidogrel–the medicines agency’s perspective
Abstract: A number of generic products containing clopidogrel as the active substance have been marketed in Austria and the EU for some time. Due to different clopidogrel salt preparations and different indications, doubts...
Author(s): Christoph Baumgärtel, MD, MSc
bioequivalence, clopidogrel, drug substitution, drugs, generics, therapeutic equivalence
DOI: 10.5639/gabij.2012.0102.019
37.273 views
